HDAC9 and Crohn disease: Considering these findings, future studies are needed to evaluate the therapeutical potential of HDAC inhibition on the modulation of long lasting pathological conditions such as chronic inflammatory diseases (arthritis and Crohn’s disease) and in cancer therapies [25,26].